2 options
Hydroxyurea for the treatment of sickle cell disease / prepared by the Johns Hopkins University Evidence-based Practice Center ; investigators, Jodi B. Segal [and others].
Connect to full text Available online
View online- Format:
- Book
- Government document
- Series:
- Evidence report/technology assessment ; no. 165.
- AHRQ publication ; no. 08-E 007.
- Evidence report/technology assessment ; no. 165
- AHRQ publication ; no. 08-E 007
- Language:
- English
- Subjects (All):
- Sickle cell anemia--Chemotherapy.
- Sickle cell anemia.
- Antineoplastic agents.
- Anemia, Sickle Cell--drug therapy.
- Antineoplastic Agents--therapeutic use.
- Hydroxyurea--therapeutic use.
- Medical Subjects:
- Anemia, Sickle Cell--drug therapy.
- Antineoplastic Agents--therapeutic use.
- Hydroxyurea--therapeutic use.
- Physical Description:
- 1 online resource (1 volume (various pagings))
- Place of Publication:
- [Rockville, Md.] : [Agency for Healthcare Research and Quality], [2008]
- Notes:
- Title from title screen (viewed on March 3, 2008).
- "February 2008."
- Includes bibliographical references (pages 77-91).
- Other Format:
- Print version: Hydroxyurea for the treatment of sickle cell disease.
- ISBN:
- 9781587633430
- 1587633434
- OCLC:
- 212626212
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.